HOXC8 and breast cancer: Overall, these results indicated that CDH11, ILF3 and HOXC8 were highly upregulated in the advanced stages of breast cancer, and high expression of CDH11, ILF3 and HOXC8 were associated with a poor DMSF for breast cancer patients.